Category Archives: News

Review highlights effective treatment options for managing patients with T2D and osteoporosisNews-Medical.netType 2 diabetes (T2D) and osteoporosis often coexist in patients, but managing both conditions can be a challenge. A comprehensive review published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism highlights the most effective …and more Source:: Osteoporosis Feed       

New class drug significantly reduces spine fracture risk in postmenopausal women with osteoporosisEurekAlert (press release)Madrid, Spain, 14 June 2017: The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference showed that, in postmenopausal women with osteoporosis, 12 months treatment with romosozumab …and more Source:: Osteoporosis Feed       

ACR Releases Guideline on prevention and treatment of glucocorticoid-induced osteoporosisMedical XpressThe American College of Rheumatology’s (ACR) updated clinical guideline for the prevention and treatment of glucocorticoid-induced osteoporosis is now available online. The guideline provides recommendations on assessing fracture risk and treatment for … Source:: Osteoporosis Feed       

TheStreet.comAmgen Osteoporosis Drug Approval Plan Derailed Over Newly Found Heart Safety Risk SignalTheStreet.com… the incidence of positively adjudicated cardiovascular serious adverse events as 12 months was 2.5% in the Evenity-treated patients compared to 1.9% in the group of patients treated with alendronate, a generic osteoporosis drug that served as the …Higher rate of heart problems … Continue reading →

Higher rate of heart problems with Amgen osteoporosis drug in trialReutersMay 21 Amgen Inc and UCB SA on Sunday said their experimental osteoporosis drug, which is awaiting a U.S. approval decision, met the primary and key secondary goals of a late stage study but a higher rate of serious heart problems were reported that …and … Continue reading →

American Association of Clinical Endocrinologists and American College of Endocrinology Respond to American …Business Wire (press release)AACE/ACE guidelines recommend that after the initiating therapy, patients should be reassessed with dual energy absorptiometry (DXA) bone mineral density (BMD) every 1 to 2 years until findings are stable, with continued interval monitoring depending …and more Source:: DXA … Continue reading →

Middletown, CT – The International Society for Clinical Densitometry, the world’s largest professional organization for bone densitometry, acknowledges and welcomes guidelines promoting best practices for quality bone density testing and treatment of osteoporosis. Our mission is to promote excellence in skeletal health assessment. We welcome the efforts of the American College of Physicians to update … Continue reading →

FDA Approves Abaloparatide for Fragility Fracture in Postmenopausal Women With OsteoporosisEndocrinology AdvisorThe US Food and Drug Administration (FDA) has approved abaloparatide (Tymlos™; Radius Health) injection for postmenopausal women with osteoporosis at an increased risk of fracture, according to a press release.1. Abaloparatide approval was based on … Source:: Osteoporosis Feed       

PulseAAFP Endorses ACP Guideline on Treating OsteoporosisAAFP NewsThe American College of Physicians (ACP) has issued a clinical practice guideline recommending that physicians treat women with osteoporosis using bisphosphonates or the biologic agent denosumab. The AAFP has endorsed the guideline, which also …The new NOGG guidelines for osteoporosisPulseall 3 news articles Source:: Osteoporosis Feed       

PulseThe new NOGG guidelines for osteoporosisPulseThe advantage to using FRAX is that it links directly into the NOGG guidelines that give you advice as to treat without DXA, advise lifestyle advice or ask for bone densitometry. Since FRAX and QFracture yield different outputs (probability of fracture …and more Source:: Densitometry Feeds       

MedscapeNew ACP Guidelines on the Treatment of OsteoporosisMedscapePhysicians should treat women with osteoporosis with one of the three main bisphosphonates or the biologic denosumab for a duration of 5 years, during which time monitoring of bone-mineral density (BMD) is not necessary, according to new clinical …Experts streamline guidelines for treating osteoporosisCNNACP issues guidelines to reduce … Continue reading →

Newly discovered genetic mutation predisposes osteoporosis patients to femur fractureMedical XpressResearchers at the Hospital del Mar Medical Research Institute (IMIM) and the University of Barcelona have uncovered a genetic mutation that makes bone vulnerable to bisphosphonates, drugs used to combat osteoporosis. Instead of strengthening bone …and more Source:: Osteoporosis Feed       

Endocrinology AdvisorBone Mineral Density Changes Related to Adrenal Incidentalomas in Menopausal WomenEndocrinology AdvisorAfter 24 months, BMD was statistically different from baseline. “Despite the general concept of [adrenal incidentaloma] and harmless general profile, in special subgroups [such] as [the] menopausal population, DXA may reveal time-dependent changes … Source:: DXA Feed       

In April, ISCD co-hosted Clinical Osteoporosis 2017 with the National Osteoporosis Foundation. The event welcomed nearly 500 clinicians, researchers, technologists, nurses and others with an interest in improving quality in skeletal health assessments and treatments. In addition to the educational sessions offered at the symposium, there were numerous networking opportunities for attendees to connect with … Continue reading →

Medical XpressOlder women show limited understanding of osteoporosisMedical Xpress(HealthDay)—Many older women have low awareness about osteoporosis and its contribution to fracture risk and a lack of understanding about the benefits of osteoporosis pharmacotherapy, according to a study published April 19 in the Journal of the … Source:: Osteoporosis Feed       

FDA Approves Radius Health’s TYMLOS™ (abaloparatide), a Bone Building Agent for the Treatment of …GlobeNewswire (press release)WALTHAM, Mass., April 28, 2017 (GLOBE NEWSWIRE) — Radius Health, Inc. (Nasdaq:RDUS), a science-driven fully integrated biopharmaceutical company that is committed to developing innovative therapeutics in the areas of osteoporosis, oncology and …and more Source:: Osteoporosis Feed       

Osteoporosis Treatment Efficacy for MenMedscapeOsteoporosis affects 2 million men in the United States, and approximately one in five white men will sustain an osteoporotic fracture in his lifetime. Men are estimated to incur 29% of all osteoporotic fractures and account for 25% of total … Source:: Osteoporosis Feed       

Osteoporosis-Drug Holidays for Low-Risk Patients: EMAS ConcursMedscapeDiscontinuation of alendronate (Fosamax, Merck) and risedronate should be considered in patients treated for more than 5 years with either drug and after 3 years if patients are treated with zoledronate, provided they are at low risk for fracture, a … Source:: Osteoporosis Feed       

International Business TimesWoolly Mammoths Had Osteoporosis: Fossils Show Bone Diseases …International Business TimesBefore woolly mammoths went extinct, they suffered terrible bone diseases like ones humans develop today.Mammoths suffered from diseases that are typical in humans | Daily …Daily Mailall 2 news articles Source:: Osteoporosis Feed       

The Cardiology Advisor (registration)Measuring Visceral Adipose Tissue With DXA to Predict Atherosclerotic CVDThe Cardiology Advisor (registration)Visceral or central adipose tissue measured via dual-energy x-ray absorptiometery (DXA) should not be included as part of atherosclerotic cardiovascular disease (ASCVD) risk assessment, according to data presented at the first joint symposium of the …and more Source:: DXA Feed … Continue reading →

Endocrinology AdvisorAccuracy of Trabecular Bone Score to Assess Fragility Fracture Risk in T1DEndocrinology Advisor… (BMI) in patients with type 1 diabetes, according to research presented at Clinical Osteoporosis 2017: A Joint Symposium of the National Osteoporosis Foundation (NOF) and the International Society of Clinical Den (ISCD) in Orlando, Florida, April …and more Source:: ISCD Feed … Continue reading →

Endocrinology AdvisorLeg Positioning During Lumbar Spine DXAEndocrinology AdvisorLeg positioning during lumbar spine dual energy x-ray absorptiometry (DXA) does not impact patients’ trabecular bone scores (TBS), according to research presented at Clinical Osteoporosis 2017, A Joint Symposium of the National Osteoporosis Foundation …and more Source:: DXA Feed       

Endocrinology AdvisorBone Age in Children as Assessed by Dual-Energy X-Ray and RadiographyEndocrinology AdvisorUse of dual-energy X-ray absorptiometry (DXA) for bone age assessment shows similar results when tested against traditional radiology, according to a study presented at Clinical Osteoporosis 2017: A Joint ISCD/NOF Symposium from April 20 to 22 in … Source:: DXA Feed       

Endocrinology AdvisorIs DXA Required to Diagnose Vertebral Fracture in Patients With Low BMD?Endocrinology AdvisorVertebral facture assessment (VFA) of acute fractures using dual-energy X-ray absorptiometry (DXA) was not superior to VFA assessed by lateral X-ray, according to a follow-up study of fracture risk in patients with normal bone mineral density (BMD). Source:: DXA Feed       

TeleECHO Clinic Improves Physician Confidence in Osteoporosis CareEndocrinology Advisor… in underserved communities demonstrated positive results, according to a study presented at Clinical Osteoporosis 2017: A Joint Symposium of the National Osteoporosis Foundation (NOF) and the International Society for Clinical Densitometry (ISCD … Source:: ISCD Feed